These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 25029428

  • 21. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
    Yoshikawa N, Ito H, Takekoshi Y, Honda M, Awazu M, Iijima K, Nakamura H, Seino Y, Takeda N, Hattori S, Matsuda I.
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):587-90. PubMed ID: 9893457
    [Abstract] [Full Text] [Related]

  • 22. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
    Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM.
    BMJ Open; 2019 Aug 01; 9(8):e027011. PubMed ID: 31375606
    [Abstract] [Full Text] [Related]

  • 23. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK, Bagga A, Srivastava RN.
    Pediatr Nephrol; 1997 Oct 01; 11(5):597-9. PubMed ID: 9323286
    [Abstract] [Full Text] [Related]

  • 24. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
    Raman V, Krishnamurthy S, Harichandrakumar KT.
    Pediatr Nephrol; 2016 Apr 01; 31(4):595-604. PubMed ID: 26759000
    [Abstract] [Full Text] [Related]

  • 25. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
    Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
    Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
    [Abstract] [Full Text] [Related]

  • 26. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 27; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 27. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
    Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M.
    Kidney Int; 2000 Sep 27; 58(3):1247-52. PubMed ID: 10972687
    [Abstract] [Full Text] [Related]

  • 28. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
    Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
    Kidney Int; 2024 May 27; 105(5):1113-1123. PubMed ID: 38360110
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 27; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 30. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan 27; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

  • 31. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome.
    Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S.
    Kidney Int; 2000 Jul 27; 58(1):317-24. PubMed ID: 10886577
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan 27; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

  • 33. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.
    Ueda N, Chihara M, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Ohnishi M, Yasaki T.
    J Pediatr; 1988 Jan 27; 112(1):122-6. PubMed ID: 3335948
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
    Christian MT, Webb NJA, Mehta S, Woolley RL, Afentou N, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Prajapati H, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
    JAMA Pediatr; 2022 Mar 01; 176(3):236-243. PubMed ID: 34928294
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.
    Basu B, Bhattacharyya S, Barua S, Naskar A, Roy B.
    Clin Exp Nephrol; 2020 Jul 01; 24(7):622-629. PubMed ID: 32201918
    [Abstract] [Full Text] [Related]

  • 36. Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.
    Weerasooriya WALK, Abeyagunawardena AS, Thalgahagoda RS.
    Eur J Pediatr; 2023 Apr 01; 182(4):1741-1747. PubMed ID: 36757496
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of zinc supplements in reducing relapses in steroid-sensitive nephrotic syndrome.
    Arun S, Bhatnagar S, Menon S, Saini S, Hari P, Bagga A.
    Pediatr Nephrol; 2009 Aug 01; 24(8):1583-6. PubMed ID: 19347367
    [Abstract] [Full Text] [Related]

  • 38. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY, Wu CY, Tsai IJ, Tsau YK.
    Nephrology (Carlton); 2010 Apr 01; 15(3):336-9. PubMed ID: 20470303
    [Abstract] [Full Text] [Related]

  • 39. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
    Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M, West Japan Cooperative Study Group of Kidney Disease in Children.
    Am J Kidney Dis; 2003 Jun 01; 41(6):1155-62. PubMed ID: 12776266
    [Abstract] [Full Text] [Related]

  • 40. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome.
    Takeda A, Takimoto H, Mizusawa Y, Simoda M.
    Pediatr Nephrol; 2001 Nov 01; 16(11):888-93. PubMed ID: 11685595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.